Antioxidative effect of an oral adsorbent, AST-120, and long-term outcomes in chronic kidney disease patients with cardiovascular disease

Hypertens Res. 2020 Oct;43(10):1128-1131. doi: 10.1038/s41440-020-0465-6. Epub 2020 May 18.

Authors

Shigeru Toyoda¹, Ryota Hashimoto², Taiyo Tezuka², Masashi Sakuma², Shichiro Abe², Tetsuya Ishikawa³, Isao Taguchi³, Teruo Inoue²

Affiliations

¹ Department of Cardiovascular Medicine, Dokkyo Medical University, Mibu, Tochigi, Japan. [email protected].
² Department of Cardiovascular Medicine, Dokkyo Medical University, Mibu, Tochigi, Japan.
³ Department of Cardiology, Saitama Medical Center, Dokkyo Medical University, Koshigaya, Saitama, Japan.

PMID: 32424202
DOI: 10.1038/s41440-020-0465-6

No abstract available

Publication types

Letter

MeSH terms

Carbon / pharmacology
Carbon / therapeutic use*
Cardiovascular Diseases / complications
Cardiovascular Diseases / prevention & control*
Humans
Oxidative Stress / drug effects*
Oxides / pharmacology
Oxides / therapeutic use*
Renal Insufficiency, Chronic / complications
Renal Insufficiency, Chronic / drug therapy*
Retrospective Studies

Substances

Oxides
Carbon
AST 120